Viracta Therapeutics
VIRX
#10572
Rank
NZ$0.65 M
Marketcap
NZ$0.01636
Share price
0.00%
Change (1 day)
-76.48%
Change (1 year)

Market capitalization of Viracta Therapeutics (VIRX)

Market cap: NZ$0.65 Million

As of February 2026 Viracta Therapeutics has a market cap of NZ$0.65 Million. This makes Viracta Therapeutics the world's 10572th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Viracta Therapeutics from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.65 M-3.13%
2025NZ$0.67 M-94.05%
2024NZ$11.27 M-67.61%
2023NZ$34.81 M-60.37%
2022NZ$87.83 M-56.08%
2021NZ$0.19 B

End of Day market cap according to different sources

On Feb 21st, 2026 the market cap of Viracta Therapeutics was reported to be:

N/A
by Nasdaq info icon info icon
NZ$0.65 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.80 B 278,263.89%๐Ÿ‡บ๐Ÿ‡ธ USA